MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,706 Approvals
Showing 61 to 80 of 1,706 approvalsPage 4 of 86

Tauvid

Authorisation: Aug 22, 2024
Eli Lilly Nederland BV

Nilotinib Accord

Authorisation: Aug 22, 2024
ACCORD HEALTHCARE SL

Steqeyma

Authorisation: Aug 22, 2024
Celltrion Healthcare Hungary Kft

Eurneffy

Authorisation: Aug 22, 2024
Alk-Abelló A/S

mResvia

Authorisation: Aug 22, 2024
Moderna Biotech Spain, S.L.

mResvia

Authorisation: Aug 22, 2024
Moderna Biotech Spain, S.L.

Piasky

Authorisation: Aug 22, 2024
Roche Registration GmbH

Balversa

Authorisation: Aug 22, 2024
Janssen-Cilag International NV

Adzynma

Authorisation: Aug 1, 2024
Takeda Manufacturing Austria AG

Avzivi

Authorisation: Jul 26, 2024
FGK Representative Service GmbH

Pomalidomide Accord

Authorisation: Jul 26, 2024
ACCORD HEALTHCARE SL

Zegalogue

Authorisation: Jul 24, 2024
Novo Nordisk A/S

Apexelsin

Authorisation: Jul 24, 2024
WhiteOak Pharmaceutical BV

Pomalidomide Krka

Authorisation: Jul 24, 2024
KRKA, d.d., Novo mesto

Pomalidomide Krka

Authorisation: Jul 24, 2024
KRKA, d.d., Novo mesto

Durveqtix

Authorisation: Jul 24, 2024
Pfizer Europe MA EEIG

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.